New Therapies for Neuroendocrine Tumors

Please read this page completely before beginning the activity. If you have any questions or need further information, please call the Memorial Sloan Kettering Cancer Center's CME Office at 646-227-2025.
New Therapies for Neuroendocrine Tumors

Leonard Saltz discusses knowledge of new therapies for neuroendocrine tumors, with the sharing of information between community physicians and Memorial Sloan Kettering Cancer Center.

Course Information

Lecture Date
March 2010
Target Audience

Primary care physicians.

Educational Objectives

The course objective is to advance and disseminate knowledge of new therapies for neuroendocrine tumors, with the sharing of information between community physicians and Memorial Sloan Kettering Cancer Center. The goal is also to inform primary care clinicians about new therapies in the treatment of neuroendocrine tumors.